Company research
PepperLime Health Acquisition Corp
CIK 1873324Updated Sep 24, 2026
Securities
PEPL price & chart
Historical security
This listing closed Mar 21, 2024. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
balance sheet · annual statements
| Line item | FY 2022 | FY 2021 |
|---|---|---|
| ASSETS | ||
| AssetsUSD | 175,398,054Source | 173,830,913Source |
| Current assets: | ||
| Cash and Cash Equivalents, at Carrying ValueUSD | 891,154Source | 1,342,403Source |
| Assets, CurrentUSD | 1,255,029Source | 2,129,007Source |
| LIABILITIES AND EQUITY | ||
| LiabilitiesUSD | 6,653,789Source | 6,174,400Source |
| Stockholders’ equity: | ||
| Retained Earnings (Accumulated Deficit)USD | -5,399,185Source | -4,043,912Source |
| Stockholders' Equity Attributable to ParentUSD | -5,398,760Source | -4,043,487Source |
| Liabilities and EquityUSD | 175,398,054Source | 173,830,913Source |
| Current liabilities: | ||
| Liabilities, CurrentUSD | 703,789Source | 224,400Source |
cash flow · annual statements
| Line item | FY 2022 | FY 2021 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 1,087,752Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -436,249Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -436,249Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 916,154Source | 1,352,403Source |
| Additional Financial Items | ||
| General and Administrative ExpenseUSD | 1,353,367Source | — |
| Investment Income, InterestUSD | 2,441,119Source | — |
| Net Income (Loss) Attributable to ParentUSD | 1,087,752Source | — |